Study finds way to cut unneeded meds in mental health patients

NCT ID NCT07043803

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a program to reduce anticholinergic medications (like benztropine) in 53 adults with schizophrenia, bipolar disorder, or other serious mental illnesses who had been taking these drugs for at least 6 months. The goal was to safely taper or stop these medications when they were no longer needed, which may improve memory and reduce side effects. The program used a stepped-wedge design across multiple healthcare sites to guide doctors and patients in reducing these drugs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHIATRIC DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder psychiatric disorder Psychotic Disorders schizoaffective disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Comprehensive Recovery Services (Pittsburgh) of Western Psychiatric Hospital, Ambulatory Clinics and Residential Programs - UPMC, Pittsburgh, PA

    Pittsburgh, Pennsylvania, 15213, United States

  • UPMC Western Behavioral Health at Safe Harbor

    Erie, Pennsylvania, 16508, United States

  • Western Behavioral Health Mon Yough

    McKeesport, Pennsylvania, 16601, United States

  • Western Behavioral Health of the Alleghenies

    Altoona, Pennsylvania, 16601, United States